Paper23398684
Regulation of G protein-coupled receptors by allosteric ligands.
Lane JR and 2 others. ACS Chem Neurosci, 2013. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation of G protein-coupled receptors by allosteric ligands. Papers, record 23398684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23398684
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ligands | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Allosteric Regulation | |
| Animals | |
| Drug Discovery | |
| Endocytosis | |
| Humans |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,284,438 | Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17284438 | PubMed |
| 2 | 19,822,761 | Endosomes: a legitimate platform for the signaling train. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19822761 | PubMed |
| 3 | 20,368,153 | A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. | Sci Transl Med | 2009 | https://conductscience.org/library/papers/20368153 | PubMed |
| 4 | 12,949,261 | Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12949261 | PubMed |
| 5 | 19,349,687 | beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19349687 | PubMed |
| 6 | 22,343,625 | Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22343625 | PubMed |
| 7 | 21,868,357 | Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin. | Sci Signal | 2011 | https://conductscience.org/library/papers/21868357 | PubMed |
| 8 | 21,757,712 | Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21757712 | PubMed |
| 9 | 15,196,559 | beta-arrestins: traffic cops of cell signaling. | Curr Opin Cell Biol | 2004 | https://conductscience.org/library/papers/15196559 | PubMed |
| 10 | 16,914,173 | mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. | Neuropharmacology | 2007 | https://conductscience.org/library/papers/16914173 | PubMed |
| 11 | 22,064,678 | Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands. | Mol Pharmacol | 2012 | https://conductscience.org/library/papers/22064678 | PubMed |
| 12 | 17,629,965 | Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. | Trends Pharmacol Sci | 2007 | https://conductscience.org/library/papers/17629965 | PubMed |
| 13 | 21,177,246 | Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21177246 | PubMed |
| 14 | 21,873,412 | Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. | Pharmacol Rev | 2011 | https://conductscience.org/library/papers/21873412 | PubMed |
| 15 | 18,606,460 | Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. | Trends Pharmacol Sci | 2008 | https://conductscience.org/library/papers/18606460 | PubMed |
| 16 | 19,940,843 | Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties. | Neuropsychopharmacology | 2010 | https://conductscience.org/library/papers/19940843 | PubMed |
| 17 | 21,920,759 | Allostery in GPCRs: 'MWC' revisited. | Trends Biochem Sci | 2011 | https://conductscience.org/library/papers/21920759 | PubMed |
| 18 | 21,183,406 | Therapeutic potential of β-arrestin- and G protein-biased agonists. | Trends Mol Med | 2011 | https://conductscience.org/library/papers/21183406 | PubMed |
| 19 | 21,772,288 | Crystal structure of the β2 adrenergic receptor-Gs protein complex. | Nature | 2011 | https://conductscience.org/library/papers/21772288 | PubMed |
| 20 | 8,396,727 | Differential signal transduction by five splice variants of the PACAP receptor. | Nature | 1993 | https://conductscience.org/library/papers/8396727 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,559,604 | Computational investigation for exploring botanical ingredients as potential negative allosteric modulators targeting metabotropic glutamate receptor 5. | Res Pharm Sci | 2026 | https://conductscience.org/library/papers/42559604 | PubMed |
| 42,454,894 | Restoration of Saccadic Eye Movements and Visually Guided Behavior in Ambient White Light with Photoswitchable Small Molecules. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42454894 | PubMed |
| 40,283,913 | Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α1A-Adrenergic Receptor. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283913 | PubMed |
| 37,305,033 | Allosteric modulation of gonadotropin receptors. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37305033 | PubMed |
| 36,801,017 | Developing novel antifungals: lessons from G protein-coupled receptors. | Trends Pharmacol Sci | 2023 | https://conductscience.org/library/papers/36801017 | PubMed |
| 36,044,544 | 2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease. | J Med Chem | 2022 | https://conductscience.org/library/papers/36044544 | PubMed |
| 35,849,804 | Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands. | J Med Chem | 2022 | https://conductscience.org/library/papers/35849804 | PubMed |
| 35,064,921 | Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications. | Pharmacol Rep | 2022 | https://conductscience.org/library/papers/35064921 | PubMed |
| 35,059,024 | Cholesterol-dependent endocytosis of GPCRs: implications in pathophysiology and therapeutics. | Biophys Rev | 2021 | https://conductscience.org/library/papers/35059024 | PubMed |
| 34,199,888 | Polyphenols and Visual Health: Potential Effects on Degenerative Retinal Diseases. | Molecules | 2021 | https://conductscience.org/library/papers/34199888 | PubMed |
| 33,122,823 | Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. | Acta Pharmacol Sin | 2021 | https://conductscience.org/library/papers/33122823 | PubMed |
| 31,454,545 | G protein-coupled receptors in acquired epilepsy: Druggability and translatability. | Prog Neurobiol | 2019 | https://conductscience.org/library/papers/31454545 | PubMed |
| 31,146,474 | Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics. | Molecules | 2019 | https://conductscience.org/library/papers/31146474 | PubMed |
| 31,121,099 | Stereospecific modulation of dimeric rhodopsin. | FASEB J | 2019 | https://conductscience.org/library/papers/31121099 | PubMed |
| 30,563,329 | Development and Testing of Druglike Screening Libraries. | J Chem Inf Model | 2019 | https://conductscience.org/library/papers/30563329 | PubMed |
| 30,048,591 | Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/30048591 | PubMed |
| 29,292,987 | Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2. | ACS Chem Neurosci | 2018 | https://conductscience.org/library/papers/29292987 | PubMed |
| 29,281,969 | Functional expression of CCL8 and its interaction with chemokine receptor CCR3. | BMC Immunol | 2017 | https://conductscience.org/library/papers/29281969 | PubMed |
| 28,560,482 | Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5. | AAPS J | 2017 | https://conductscience.org/library/papers/28560482 | PubMed |
| 28,029,647 | Peptide-guided targeting of GPR55 for anti-cancer therapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/28029647 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VN1R17P | 441,931 | PubTator's text mining | https://conductscience.org/library/genes/441931 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23398684
GET https://conductscience.org/api/papers/v1/23398684/references?page=2